VVOS icon

Vivos Therapeutics

10 hedge funds and large institutions have $3.88M invested in Vivos Therapeutics in 2020 Q4 according to their latest regulatory filings, with 10 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Holders
10
Holders Change
+10
Holders Change %
% of All Funds
0.18%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
10
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
RA
1
Royce & Associates
New York
$1.77M 300,000 +300,000 New
KJHP
2
K.J. Harrison & Partners
Ontario, Canada
$540K 91,322 +91,322 New
Millennium Management
3
Millennium Management
New York
$493K 83,426 +83,426 New
KPF
4
K2 Principal Fund
Ontario, Canada
$304K 51,394 +51,394 New
MA
5
MYDA Advisors
New York
$260K 44,000 +44,000 New
MS
6
Maven Securities
Jersey
$197K 32,000 +32,000 New
Jane Street
7
Jane Street
New York
$191K 32,237 +32,237 New
PCM
8
Perkins Capital Management
Minnesota
$118K 20,000 +20,000 New
Morgan Stanley
9
Morgan Stanley
New York
$6K 1,000 +1,000 New
Walleye Capital
10
Walleye Capital
New York
$440 74,500 +74,500 New
CFGS
11
Concourse Financial Group Securities
Alabama